Tourmaline Bio Statistics
Total Valuation
Tourmaline Bio has a market cap or net worth of $427.66 million. The enterprise value is $169.60 million.
Important Dates
The last earnings date was Thursday, March 13, 2025, before market open.
Earnings Date | Mar 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Tourmaline Bio has 25.69 million shares outstanding. The number of shares has increased by 433.98% in one year.
Current Share Class | 25.69M |
Shares Outstanding | 25.69M |
Shares Change (YoY) | +433.98% |
Shares Change (QoQ) | +0.11% |
Owned by Insiders (%) | 8.43% |
Owned by Institutions (%) | 66.52% |
Float | 15.58M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.42 |
P/TBV Ratio | 1.43 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 30.18, with a Debt / Equity ratio of 0.00.
Current Ratio | 30.18 |
Quick Ratio | 28.99 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -28.99% and return on invested capital (ROIC) is -22.18%.
Return on Equity (ROE) | -28.99% |
Return on Assets (ROA) | -21.60% |
Return on Invested Capital (ROIC) | -22.18% |
Return on Capital Employed (ROCE) | -29.90% |
Revenue Per Employee | n/a |
Profits Per Employee | -$989,324 |
Employee Count | 74 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.29% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -27.29% |
50-Day Moving Average | 15.33 |
200-Day Moving Average | 19.11 |
Relative Strength Index (RSI) | 54.54 |
Average Volume (20 Days) | 357,023 |
Short Selling Information
The latest short interest is 3.41 million, so 13.28% of the outstanding shares have been sold short.
Short Interest | 3.41M |
Short Previous Month | 3.42M |
Short % of Shares Out | 13.28% |
Short % of Float | 21.89% |
Short Ratio (days to cover) | 12.56 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -89.73M |
Pretax Income | -35.69M |
Net Income | -73.21M |
EBITDA | -89.69M |
EBIT | -89.73M |
Earnings Per Share (EPS) | -$2.89 |
Full Income Statement Balance Sheet
The company has $258.30 million in cash and $244,000 in debt, giving a net cash position of $258.06 million or $10.05 per share.
Cash & Cash Equivalents | 258.30M |
Total Debt | 244,000 |
Net Cash | 258.06M |
Net Cash Per Share | $10.05 |
Equity (Book Value) | 300.05M |
Book Value Per Share | 11.71 |
Working Capital | 259.93M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$77.26 million and capital expenditures -$9,000, giving a free cash flow of -$77.27 million.
Operating Cash Flow | -77.26M |
Capital Expenditures | -9,000 |
Free Cash Flow | -77.27M |
FCF Per Share | -$3.01 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |